[1]
G. Yosipovitch, “Secukinumab Provides Rapid Relief From Itching and Pain in Patients with Moderate-to-Severe Psoriasis: Patient Symptom Diary Data from Two Phase 3, Randomized, Placebo-controlled Clinical Trials”, Acta Derm Venereol, vol. 99, no. 9, pp. 820–821, Jun. 2019.